CONMED
Stock Forecast, Prediction & Price Target

CONMED Financial Estimates

CONMED Revenue Estimates

CONMED EBITDA Estimates

CONMED Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026 12/31/2027
Revenue
 
% change YoY
$1.01B
 
N/A
$1.04B
 
3.44%
$1.24B
 
19.06%
Avg: $1.45B
Low: $1.43B
High: $1.47B
avg. 16.56%
Avg: $1.55B
Low: $1.50B
High: $1.58B
avg. 7.38%
Avg: $1.68B
Low: $1.62B
High: $1.70B
avg. 7.93%
Net Income
 
% change YoY
$62.54M
 
N/A
$-80.58M
 
-228.84%
$64.45M
 
179.99%
Avg: $146.51M
Low: $136.28M
High: $158.68M
avg. 127.29%
Avg: $180.93M
Low: $169.72M
High: $190.86M
avg. 23.49%
Avg: $235.97M
Low: $225.15M
High: $240.35M
avg. 30.42%
EBITDA
 
% change YoY
$108.59M
 
N/A
$-41.95M
 
-138.63%
$192.47M
 
558.74%
Avg: $99.95M
Low: $98.57M
High: $101.33M
avg. -48.06%
Avg: $107.33M
Low: $103.55M
High: $108.86M
avg. 7.38%
Avg: $115.85M
Low: $111.76M
High: $117.50M
avg. 7.93%
EPS
 
% change YoY
$2.14
 
N/A
-$2.68
 
-225.23%
$2.1
 
178.35%
Avg: $4.68
Low: $4.32
High: $5.03
avg. 122.61%
Avg: $5.72
Low: $5.38
High: $6.05
avg. 22.24%
Avg: $7.48
Low: $7.14
High: $7.62
avg. 30.88%
Operating Expenses
 
% change YoY
$458.31M
 
N/A
$501.19M
 
9.35%
$555.64M
 
10.86%
Avg: $599.95M
Low: $591.67M
High: $608.22M
avg. 7.97%
Avg: $644.24M
Low: $621.51M
High: $653.42M
avg. 7.38%
Avg: $695.37M
Low: $670.84M
High: $705.28M
avg. 7.93%

FAQ

What is CONMED stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 60.40% in 2025-2027.

We have gathered data from 5 analysts. Their low estimate is 136.28M, average is 146.51M and high is 158.68M.

What is CONMED stock revenue growth forecast?

Wall Street analysts forecast annual average revenue growth of 10.62% in 2025-2027.

We have gathered data from 7 analysts. Their low revenue estimate is $1.43B, average is $1.45B and high is $1.47B.

What is CONMED stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 58.58% in 2025-2027.

We have gathered data from 5 analysts. Their low earnings per share estimate is $4.32, average is $4.68 and high is $5.03.

What is the best performing analyst?

In the last twelve months analysts have been covering CONMED stock. The most successful analyst is Matt O'Brien whose win rate is 50%. He has correctly predicted 1/2 price targets.